The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Mice that were free to scratch their itchy ears saw the number of immune cells go up and levels of infection-causing bacteria decline ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The drug, known as suzetrigine, is the first new painkiller approved in the U.S. since 1998. It can be used to relieve pain after surgery or injury, and some researchers say it might be the start of a ...